BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29227326)

  • 1. Sudden Intracranial Hemorrhage in a Patient With Atypical Chronic Myeloid Leukemia in Chronic Phase.
    Kouzuki K; Umeda K; Saida S; Kato I; Hiramatsu H; Funaki T; Kanda K; Muramatsu H; Yoshida K; Ogawa S; Adachi S
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):e553-e556. PubMed ID: 29227326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic-phase chronic myeloid leukemia with intracranial hemorrhage complicated with tumor lysis syndrome].
    Oyama C; Arakawa Y; Ikeda Y; Aoki T; Kubota Y; Isobe K; Mori M; Kurihara J; Koh K
    Rinsho Ketsueki; 2021; 62(5):346-351. PubMed ID: 34108312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydroxyurea on blood viscosity in chronic myelogenous leukemia with hyperleukocytosis.
    Sharma K; Rao S; Bhat SV
    Physiol Chem Phys Med NMR; 1991; 23(4):261-8. PubMed ID: 1812505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
    Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
    J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia].
    Watanabe N; Tani M; Tanaka Y; Kurata M; Matsushita A; Maeda A; Nagai K; Takahashi T
    Rinsho Ketsueki; 2004 Mar; 45(3):243-6. PubMed ID: 15103940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic oscillations of leucocyte counts in chronic myeloid leukaemia.
    Malhotra OP; Salam SR
    Postgrad Med J; 1991 Jan; 67(783):87-9. PubMed ID: 2057439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Myeloid Leukaemia with Sudden Bilateral Deafness and Leg Ulcer Associated with Hydroxyurea Therapy.
    Ugwu NI; Okoye AE; Ugwu CN; Ibiam FA; Nnachi OA; Ugwu GC; Okoh NU
    West Afr J Med; 2021 May; 38(5):502-506. PubMed ID: 34051725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CHRONIC MYELOID LEUKEMIA IN A YOUNG MALE PRESENTING WITH BILATERAL CALF PAIN DUE TO LEUKOSTASIS].
    Rottenstreich M; Lavie M; Rottenstreich A
    Harefuah; 2015 May; 154(5):296-8, 340. PubMed ID: 26168638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial Hemorrhage Associated With T-Cell Acute Lymphoblastic Leukemia With Hyperleukocytosis: A Case Report.
    Ağrali Eröz N; Derviş MF; Tuna Deveci R; Sencer S; Peker B; Demirkol D
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e812-e815. PubMed ID: 33797454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].
    Hehlmann R; Heimpel H; Heinze B; Georgii A; Kolb HJ; Hossfeld DK; von Wussow P; Hochhaus A; Griesshammer M; Diehl V
    Onkologie; 1991 Feb; 14(1):66-73. PubMed ID: 2057176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
    Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
    Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukopheresis for profound hyperleukocytosis.
    Chekol SS; Bhatnagar B; Gojo I; Hess JR
    Transfus Apher Sci; 2012 Feb; 46(1):29-31. PubMed ID: 22082657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spurious hypoxemia due to hyperleukocytosis. Report of one case].
    Florenzano V P; Letelier S LM; Durán S C J; Sanhueza C C; Toro C L
    Rev Med Chil; 2012 Apr; 140(4):503-6. PubMed ID: 22854697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Symmetrical foot ulcer in chronic myeloid leukemia treated with hydroxyurea (Litalir)].
    Reichenberger F
    Praxis (Bern 1994); 1998 Oct; 87(41):1370-2. PubMed ID: 9828669
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolution of hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):21-6. PubMed ID: 1641653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
    Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
    Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia.
    Carella AM
    Leuk Lymphoma; 2001 Jan; 40(3-4):447-8. PubMed ID: 11426572
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
    Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
    Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imatinib therapy in chronic myeloid leukemia].
    Egyed M; Kollár B; Rajnics P; Karádi E; Matolcsi A
    Orv Hetil; 2008 Aug; 149(32):1509-12. PubMed ID: 18672441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.
    Kolitz JE; Kempin SJ; Schluger A; Wong GY; Berman E; Jhanwar S; Arlin ZA; Gee T; Clarkson BD
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):27-33. PubMed ID: 1641654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.